Inactive Instrument

Amyris, Inc.

AMRS

US03236M2008

Amyris, Inc. Announces Resignation of Susanna McFerson as Chief Business Officer, Effective January 16, 2015

January 16, 2015 at 03:01 am IST

On January 9, 2015, Susanna McFerson, chief business officer of Amyris, Inc. announced her resignation from the company, effective January 16, 2015, to pursue other opportunities.

Latest news about Amyris, Inc.

Han Kieftenbeld to leave as Chief Financial Officer of Amyris, Inc	08/05	CI
Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors	08/05	CI
Amyris, Inc. Announces Chief Executive Officer Changes	08/05	CI
Amyris, Inc. Emerged from Bankruptcy	07/05	CI
North American Morning Briefing : Stock Futures -2-	13/03	DJ
Third Amended Joint Reorganization Plan Approved for Amyris, Inc.	07/02	CI
Third Amended Joint Reorganization Plan Filed by Amyris, Inc.	22/01	CI
Notice for Auction Cancellation Filed by Amyris, Inc.	17/01	CI
Foris Ventures Provides Information to the Shareholders	06/01	CI
Advance Auto Parts Names Elizabeth Dreyer as Chief Accounting Officer	05/01	MT
First Motion for Exclusivity Period Extension Approved For Amyris, Inc.	05/01	CI
Amyris, Inc., Amyris Clean Beauty, Inc., and Aprinnova, LLC Enter into Amendment to That Certain Senior Secured Super Priority Debtor in Possession Loan Agreement	05/01	CI
Motion for Asset Sale Approved for Amyris, Inc.	04/01	CI
Dr. Reddy's Laboratories Acquires MenoLabs Business	03/01	MT
Mounting Geopolitical Tensions Weigh Down Indian Equities on Wednesday	03/01	MT
Dr. Reddy's Acquires Women's Health and Diery Supplements Brand MenoLabs	03/01	MT
Amyris, Inc. cancelled the transaction announced on December 29, 2022	29/12	CI
Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024	28/12	CI
Motion for Asset Sale Approved for Amyris, Inc.	21/12	CI
Motion for Asset Sale Approved for Amyris, Inc.	21/12	CI
Motion for Asset Sale Approved for Amyris, Inc.	21/12	CI
Bidding Procedure Approved for Amyris, Inc.	20/12	CI
Motion for Asset Sale Filed by Amyris, Inc.	15/12	CI
Notice of Selection of Successful Bidder by Amyris, Inc.	14/12	CI
Motion for Asset Sale Approved for Amyris, Inc.	12/12	CI

Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Companyâs sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ECOLAB INC.	+19.99%	67.97B
SIKA AG	-6.03%	45.92B
GIVAUDAN SA	+22.27%	43.74B
FUJIFILM HOLDINGS CORPORATION	+33.20%	28.16B
EMS-CHEMIE HOLDING AG	+8.15%	19.17B
SYMRISE AG	+14.71%	17.12B
CELANESE CORPORATION	-13.18%	14.73B
POSCO FUTURE M CO., LTD.	-27.99%	14.52B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-32.33%	11.64B

Other Specialty Chemicals